Sanofi Aventis Letter
At the request of sanofi aventis, and as a public service, ISMP has agreed to provide a link to a letter from them regarding recent reports of label adherence issues with LOVENOX (enoxaparin) 30 mg and 40 mg prefilled unit dose syringes. The letter provides additional information about avoiding needlesticks when using the syringe, including the need to inspect syringes when removing them from the packaging, then assuring the label is properly adhered to the syringe before use. The company is taking the required steps to address the issues that were identified regarding this matter
in our July 29, 2010 newsletter. The letter from the company can downloaded below.